Pregabalin Market Research Report by Dosage Forms (Extended Release, Oral Capsule, and Oral Solution), Drug Class, Application, End-Users, Distribution Channel, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030- Product Image

Sale

Pregabalin Market Research Report by Dosage Forms (Extended Release, Oral Capsule, and Oral Solution), Drug Class, Application, End-Users, Distribution Channel, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Report
256 Pages
January 2023
Region: Global
360iResearch™
ID: 5666543

UP TO €850EUR$895USD£752GBP OFF until Mar 31^st 2023

The Global Pregabalin Market size was estimated at USD 1,050.75 million in 2022, USD 1,126.38 million in 2023, and is projected to grow at a CAGR of 7.67% to reach USD 1,898.90 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Pregabalin Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Pregabalin Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Pregabalin Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Pregabalin Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Pregabalin Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Dosage Forms, the market is studied across Extended Release, Oral Capsule, Oral Solution, and Oral Tablet.
Based on Drug Class, the market is studied across Anticonvulsants and Fibromyalgia Agents.
Based on Application, the market is studied across Anxiety Disorder, Epilepsy, and Neuropathic Pain.
Based on End-Users, the market is studied across Homecare, Hospitals, Research institute, and Specialty Clinics.
Based on Distribution Channel, the market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Pregabalin Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Pregabalin Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Pregabalin Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Pregabalin Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pregabalin Market, including Almelo Private Limited, Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, BAL Pharma Ltd., Cipla Limited, Dongbang FTL, Genesis Biotec Inc., Hikal Ltd., Lupin Limited, Medley Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Limited.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pregabalin Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pregabalin Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pregabalin Market?
4. What is the competitive strategic window for opportunities in the Global Pregabalin Market?
5. What are the technology trends and regulatory frameworks in the Global Pregabalin Market?
6. What is the market share of the leading vendors in the Global Pregabalin Market?
7. What modes and strategic moves are considered suitable for entering the Global Pregabalin Market?

Frequently Asked Questions about the Global Pregabalin Market

What is the estimated value of the Global Pregabalin Market?

The Global Pregabalin Market was estimated to be valued at $1050.75 Million in 2022.

What is the growth rate of the Global Pregabalin Market?

The growth rate of the Global Pregabalin Market is 7.6%, with an estimated value of $1898.9 Million by 2030.

What is the forecasted size of the Global Pregabalin Market?

The Global Pregabalin Market is estimated to be worth $1898.9 Million by 2030.

Who are the key companies in the Global Pregabalin Market?

Key companies in the Global Pregabalin Market include Almelo Private Limited, Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, BAL Pharma Ltd., Cipla Limited, Dongbang FTL, Genesis Biotec Inc., Hikal Ltd. and Medley Pharmaceuticals Limited.

Report Attribute	Details
No. of Pages	256
Published	January 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	USD 1050.75 Million
Forecasted Market Value ( USD ) by 2030	USD 1898.9 Million
Compound Annual Growth Rate	7.6%
Regions Covered	Global
No. of Companies Mentioned	15

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of epilepsy and anxiety disorders
5.1.1.2. Favorable government initiatives for raising awareness for anxiety issues
5.1.1.3. Rising geriartic population with neuropathic pain
5.1.2. Restraints
5.1.2.1. Presence of substitutes and lack of awareness
5.1.3. Opportunities
5.1.3.1. Rising approvals of generic versions of the medicine
5.1.3.2. Advancements and product enhancements for pregabalin
5.1.4. Challenges
5.1.4.1. Adverse effects on health and product recalls
5.2. Cumulative Impact of COVID-19

6. Pregabalin Market, by Dosage Forms

6.1. Introduction
6.2. Extended Release
6.3. Oral Capsule
6.4. Oral Solution
6.5. Oral Tablet

7. Pregabalin Market, by Drug Class

7.1. Introduction
7.2. Anticonvulsants
7.3. Fibromyalgia Agents

8. Pregabalin Market, by Application

8.1. Introduction
8.2. Anxiety Disorder
8.3. Epilepsy
8.4. Neuropathic Pain

9. Pregabalin Market, by End-Users

9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Research institute
9.5. Specialty Clinics

10. Pregabalin Market, by Distribution Channel

10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy

11. Americas Pregabalin Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Pregabalin Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Pregabalin Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles

15.1. Almelo Private Limited
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Amneal Pharmaceuticals LLC
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Aurobindo Pharma Limited
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Bal Pharma Limited
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Biomax Biotechnics Private Limited
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Changzhou Pharmaceutical Factory
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Cipla Limited
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Dongbang FTL
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Genesis Biotec Inc.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Glenmark Pharmaceuticals Ltd.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Hikal Ltd.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Lupin Limited
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Medley Pharmaceuticals Limited
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Novartis AG
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Pfizer Inc.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Teva Pharmaceutical Industries Ltd.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Torrent Pharmaceuticals Ltd.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Viatris Inc.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. ZCL Chemicals Ltd.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Zydus Group
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL PREGABALIN MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PREGABALIN MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL PREGABALIN MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL PREGABALIN MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL PREGABALIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL PREGABALIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL PREGABALIN MARKET DYNAMICS
FIGURE 11. GLOBAL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2021 VS 2027 (%)
FIGURE 12. GLOBAL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY DOSAGE FORMS, 2027
FIGURE 14. GLOBAL PREGABALIN MARKET SIZE, BY EXTENDED RELEASE, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL PREGABALIN MARKET SIZE, BY ORAL CAPSULE, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL PREGABALIN MARKET SIZE, BY ORAL SOLUTION, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL PREGABALIN MARKET SIZE, BY ORAL TABLET, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (%)
FIGURE 19. GLOBAL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG CLASS, 2027
FIGURE 21. GLOBAL PREGABALIN MARKET SIZE, BY ANTICONVULSANTS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL PREGABALIN MARKET SIZE, BY FIBROMYALGIA AGENTS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL PREGABALIN MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 24. GLOBAL PREGABALIN MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 26. GLOBAL PREGABALIN MARKET SIZE, BY ANXIETY DISORDER, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL PREGABALIN MARKET SIZE, BY EPILEPSY, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL PREGABALIN MARKET SIZE, BY END-USERS, 2021 VS 2027 (%)
FIGURE 30. GLOBAL PREGABALIN MARKET SIZE, BY END-USERS, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USERS, 2027
FIGURE 32. GLOBAL PREGABALIN MARKET SIZE, BY HOMECARE, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL PREGABALIN MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 37. GLOBAL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2027
FIGURE 39. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL PREGABALIN MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
FIGURE 41. GLOBAL PREGABALIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 42. AMERICAS PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 44. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 45. AMERICAS PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 46. ARGENTINA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. BRAZIL PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. CANADA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. MEXICO PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. UNITED STATES PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 52. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 53. UNITED STATES PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 54. ASIA-PACIFIC PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 56. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 57. ASIA-PACIFIC PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 58. AUSTRALIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. CHINA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. INDIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. INDONESIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. JAPAN PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. MALAYSIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. PHILIPPINES PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. SINGAPORE PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. SOUTH KOREA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. TAIWAN PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. THAILAND PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. VIETNAM PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 74. DENMARK PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. EGYPT PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. FINLAND PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. FRANCE PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. GERMANY PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. ISRAEL PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. ITALY PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. NETHERLANDS PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. NIGERIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. NORWAY PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. POLAND PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. QATAR PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. RUSSIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. SAUDI ARABIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. SOUTH AFRICA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. SPAIN PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. SWEDEN PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. SWITZERLAND PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. TURKEY PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 94. UNITED KINGDOM PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 95. GLOBAL PREGABALIN MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 96. GLOBAL PREGABALIN MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 97. GLOBAL PREGABALIN MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021

List of Tables

TABLE 1. GLOBAL PREGABALIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL PREGABALIN MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL PREGABALIN MARKET SIZE, BY EXTENDED RELEASE, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL PREGABALIN MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL PREGABALIN MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL PREGABALIN MARKET SIZE, BY ORAL CAPSULE, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL PREGABALIN MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL PREGABALIN MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL PREGABALIN MARKET SIZE, BY ORAL SOLUTION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL PREGABALIN MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL PREGABALIN MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL PREGABALIN MARKET SIZE, BY ORAL TABLET, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL PREGABALIN MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL PREGABALIN MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL PREGABALIN MARKET SIZE, BY ANTICONVULSANTS, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL PREGABALIN MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL PREGABALIN MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL PREGABALIN MARKET SIZE, BY FIBROMYALGIA AGENTS, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL PREGABALIN MARKET SIZE, BY FIBROMYALGIA AGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL PREGABALIN MARKET SIZE, BY FIBROMYALGIA AGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL PREGABALIN MARKET SIZE, BY ANXIETY DISORDER, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL PREGABALIN MARKET SIZE, BY ANXIETY DISORDER, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL PREGABALIN MARKET SIZE, BY ANXIETY DISORDER, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL PREGABALIN MARKET SIZE, BY EPILEPSY, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL PREGABALIN MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL PREGABALIN MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL PREGABALIN MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL PREGABALIN MARKET SIZE, BY HOMECARE, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL PREGABALIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL PREGABALIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL PREGABALIN MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL PREGABALIN MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL PREGABALIN MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL PREGABALIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL PREGABALIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL PREGABALIN MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL PREGABALIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL PREGABALIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL PREGABALIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
TABLE 57. GLOBAL PREGABALIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 58. GLOBAL PREGABALIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 59. AMERICAS PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 60. AMERICAS PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 61. AMERICAS PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 62. AMERICAS PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 63. AMERICAS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 64. AMERICAS PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 65. AMERICAS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 66. ARGENTINA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 67. ARGENTINA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 68. ARGENTINA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 69. ARGENTINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 70. ARGENTINA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 71. ARGENTINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 72. BRAZIL PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 73. BRAZIL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 74. BRAZIL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 75. BRAZIL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 76. BRAZIL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 77. BRAZIL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 78. CANADA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 79. CANADA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 80. CANADA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 81. CANADA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 82. CANADA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 83. CANADA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 84. MEXICO PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 85. MEXICO PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 86. MEXICO PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 87. MEXICO PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 88. MEXICO PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 89. MEXICO PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 90. UNITED STATES PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 91. UNITED STATES PREGABALIN MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 92. UNITED STATES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 93. UNITED STATES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 94. UNITED STATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 95. UNITED STATES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 96. UNITED STATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 97. ASIA-PACIFIC PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 98. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 99. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 100. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 101. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 102. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 103. ASIA-PACIFIC PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 104. AUSTRALIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 105. AUSTRALIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 106. AUSTRALIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 107. AUSTRALIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 108. AUSTRALIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 109. AUSTRALIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 110. CHINA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 111. CHINA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 112. CHINA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 113. CHINA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 114. CHINA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 115. CHINA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 116. INDIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 117. INDIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 118. INDIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 119. INDIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 120. INDIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 121. INDIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 122. INDONESIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 123. INDONESIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 124. INDONESIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 125. INDONESIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 126. INDONESIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 127. INDONESIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 128. JAPAN PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 129. JAPAN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 130. JAPAN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 131. JAPAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 132. JAPAN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 133. JAPAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 134. MALAYSIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 135. MALAYSIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 136. MALAYSIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 137. MALAYSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 138. MALAYSIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 139. MALAYSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 140. PHILIPPINES PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 141. PHILIPPINES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 142. PHILIPPINES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 143. PHILIPPINES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 144. PHILIPPINES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 145. PHILIPPINES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 146. SINGAPORE PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 147. SINGAPORE PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 148. SINGAPORE PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 149. SINGAPORE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 150. SINGAPORE PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 151. SINGAPORE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 152. SOUTH KOREA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 153. SOUTH KOREA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 154. SOUTH KOREA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 155. SOUTH KOREA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 156. SOUTH KOREA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 157. SOUTH KOREA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 158. TAIWAN PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 159. TAIWAN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 160. TAIWAN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 161. TAIWAN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 162. TAIWAN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 163. TAIWAN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 164. THAILAND PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 165. THAILAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 166. THAILAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 167. THAILAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 168. THAILAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 169. THAILAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 170. VIETNAM PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 171. VIETNAM PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 172. VIETNAM PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 173. VIETNAM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 174. VIETNAM PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 175. VIETNAM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 183. DENMARK PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 184. DENMARK PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 185. DENMARK PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 186. DENMARK PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 187. DENMARK PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 188. DENMARK PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 189. EGYPT PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 190. EGYPT PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 191. EGYPT PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 192. EGYPT PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 193. EGYPT PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 194. EGYPT PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 195. FINLAND PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 196. FINLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 197. FINLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 198. FINLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 199. FINLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 200. FINLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 201. FRANCE PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 202. FRANCE PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 203. FRANCE PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 204. FRANCE PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 205. FRANCE PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 206. FRANCE PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 207. GERMANY PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 208. GERMANY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 209. GERMANY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 210. GERMANY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 211. GERMANY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 212. GERMANY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 213. ISRAEL PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 214. ISRAEL PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 215. ISRAEL PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 216. ISRAEL PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 217. ISRAEL PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 218. ISRAEL PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 219. ITALY PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 220. ITALY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 221. ITALY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 222. ITALY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 223. ITALY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 224. ITALY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 225. NETHERLANDS PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 226. NETHERLANDS PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 227. NETHERLANDS PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 228. NETHERLANDS PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 229. NETHERLANDS PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 230. NETHERLANDS PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 231. NIGERIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 232. NIGERIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 233. NIGERIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 234. NIGERIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 235. NIGERIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 236. NIGERIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 237. NORWAY PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 238. NORWAY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 239. NORWAY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 240. NORWAY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 241. NORWAY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 242. NORWAY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 243. POLAND PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 244. POLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 245. POLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 246. POLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 247. POLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 248. POLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 249. QATAR PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 250. QATAR PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 251. QATAR PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 252. QATAR PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 253. QATAR PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 254. QATAR PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 255. RUSSIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 256. RUSSIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 257. RUSSIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 258. RUSSIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 259. RUSSIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 260. RUSSIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 261. SAUDI ARABIA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 262. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 263. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 264. SAUDI ARABIA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 265. SAUDI ARABIA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 266. SAUDI ARABIA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 267. SOUTH AFRICA PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 268. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 269. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 270. SOUTH AFRICA PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 271. SOUTH AFRICA PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 272. SOUTH AFRICA PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 273. SPAIN PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 274. SPAIN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 275. SPAIN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 276. SPAIN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 277. SPAIN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 278. SPAIN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 279. SWEDEN PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 280. SWEDEN PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 281. SWEDEN PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 282. SWEDEN PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 283. SWEDEN PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 284. SWEDEN PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 285. SWITZERLAND PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 286. SWITZERLAND PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 287. SWITZERLAND PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 288. SWITZERLAND PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 289. SWITZERLAND PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 290. SWITZERLAND PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 291. TURKEY PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 292. TURKEY PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 293. TURKEY PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 294. TURKEY PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 295. TURKEY PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 296. TURKEY PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 303. UNITED KINGDOM PREGABALIN MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 304. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DOSAGE FORMS, 2018-2027 (USD MILLION)
TABLE 305. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD MILLION)
TABLE 306. UNITED KINGDOM PREGABALIN MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 307. UNITED KINGDOM PREGABALIN MARKET SIZE, BY END-USERS, 2018-2027 (USD MILLION)
TABLE 308. UNITED KINGDOM PREGABALIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 309. GLOBAL PREGABALIN MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 310. GLOBAL PREGABALIN MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 311. GLOBAL PREGABALIN MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 312. GLOBAL PREGABALIN MARKET RANKING, BY KEY PLAYER, 2021
TABLE 313. GLOBAL PREGABALIN MARKET SHARE, BY KEY PLAYER, 2021
TABLE 314. GLOBAL PREGABALIN MARKET MERGER & ACQUISITION
TABLE 315. GLOBAL PREGABALIN MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 316. GLOBAL PREGABALIN MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 317. GLOBAL PREGABALIN MARKET INVESTMENT & FUNDING
TABLE 318. GLOBAL PREGABALIN MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 319. GLOBAL PREGABALIN MARKET: LICENSE & PRICING